Vaccine Responses in Patients With B Cell Malignancies
Clinical trial NCT05170399 · RECRUITING
Trial details
- NCT number
- NCT05170399
- Sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-14
- Primary completion
- 2036-11-15
- Enrollment
- 350
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.